---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-26-000770"
form_type: "8-K"
ticker: "ARCT"
cik: "0001768224"
company_name: "Arcturus Therapeutics Holdings Inc."
filed_at: "2026-06-05T21:20:32+00:00"
generated_at: "2026-06-05T21:22:35.746655+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "high"
source: SEC EDGAR
---

# Arcturus Therapeutics shareholders elect all eight director nominees, approve say-on-pay, and ratify Deloitte as auditor

## Summary
- All eight director nominees (Farrell, Payne, Barlow, Holmes, Marquet, Marantz, Markels, Slaoui) elected with over 15M votes each.
- Non-binding advisory say-on-pay approved: 15.25M for, 327,647 against, 176,375 abstain.
- Ratification of Deloitte as independent auditor for 2026 approved: 21.38M for, 46,823 against, 10,349 abstain.
- Quorum of 21.44M shares present out of 28.42M shares entitled to vote.
- All proposals passed with no significant opposition; no other business transacted.

## SEC filing metadata
- accession: 0001193805-26-000770
- form_type: 8-K
- ticker: ARCT
- cik: 0001768224
- company_name: Arcturus Therapeutics Holdings Inc.
- filed_at: 2026-06-05T21:20:32+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768224/000119380526000770/0001193805-26-000770-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768224/000119380526000770/e665552_8k-arct.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-26-000770
- JSON: https://secwatch.observer/filing/0001193805-26-000770.json
- Plain text: https://secwatch.observer/filing/0001193805-26-000770.txt

## Key facts
- Shareholder Votes
  Arcturus Therapeutics Holdings Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm at the 2026-06-05 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-05
  source text: Proposal No. 3 For Against Abstain Broker Non-Votes Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768224/000119380526000770/0001193805-26-000770-index.htm
- Shareholder Votes
  Arcturus Therapeutics Holdings Inc. shareholders approved Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation at the 2026-06-05 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-05
  source text: Proposal No. 2 For Against Abstain Broker Non-Votes Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768224/000119380526000770/0001193805-26-000770-index.htm
- Shareholder Votes
  Arcturus Therapeutics Holdings Inc. shareholders approved Election of eight directors at the 2026-06-05 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-05
  source text: Proposal No. 1 For Withhold Broker Non-Votes Approval of the election of the following individuals as directors of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768224/000119380526000770/0001193805-26-000770-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.